Kiniksa Pharmaceuticals International (KNSA) executive compensation, 2026 proxy

Sanj K. Patel, Chief Executive Officer and Chairman of the Board, was paid $10.8M in 2025, up 54% from $7M the year before. The CEO-to-median-employee pay ratio was 35:1, on median employee pay of $310,707.

Filed
April 16, 2026
Annual meeting
May 29, 2026
Pay year
2025
Named executives
5
CEO total pay
$10.8M+54% vs prior year
CEO to median employee
35:1median $310,707
CEO pay in equity
79%$8.5M in awards
CEO Total Compensation
$10.8MFiscal year 2025
CEO Prior Year Total
$7.0MFiscal year 2024
CEO Salary
$943,129Fiscal year 2025
Median Employee Pay
$310,707Fiscal year 2025
CEO to Median Pay Ratio
35:1Fiscal year 2025

How Patel was paid

$10.8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary9%Stock awards35%Option awards44%Non-equity incentive12%All other compensation0%

Named executive officers

ExecutiveTotal
Sanj K. PatelChief Executive Officer and Chairman of the Board$10,782,661
John F. Paolini, M.D., Ph.D.Executive Vice President and Chief Medical Officer$3,570,655
Eben TessariExecutive Vice President and Chief Operating Officer$3,566,231
Ross MoatExecutive Vice President and Chief Commercial Officer$3,638,001
Mark RagosaSenior Vice President and Chief Financial Officer$3,283,055

What changed and why

  • $10.8MChief Executive Officer Sanj K. Patel received total compensation of $10,782,661 in fiscal year 2025.
  • $7MTotal compensation for the chief executive officer increased from $7,009,672 in the prior fiscal year.
  • The ratio of the chief executive officer compensation to the median employee total compensation was 35 to 1.
  • $311KThe median employee annual total compensation was established at $310,707 for 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.